The 20 Best Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL) Doctors Near Me in New Jersey, US

Kenneth Nahum is a Hematologist Oncology provider practicing medicine in Howell, New Jersey. Dr. Nahum is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 70 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Lynch Syndrome, Bone Marrow Aspiration, and Fasciotomy. Dr. Nahum is board certified in American Board Of Internal Medicine and Hematology.

Vivek Maheshwari is a General Surgeon and a Surgical Oncologist practicing medicine in West Orange, New Jersey. Dr. Maheshwari is rated as an Advanced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Hernia, Gallstones, Choledocholithiasis, Colostomy, and Hernia Surgery. Dr. Maheshwari is currently accepting new patients.

Anita Kumar is a Hematologist and an Oncologist practicing medicine in Basking Ridge, New Jersey. She has been practicing medicine for over 18 years. Dr. Kumar is rated as an Advanced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). She is also highly rated in 22 other conditions, according to our data. Her clinical expertise encompasses Mantle Cell Lymphoma (MCL), Gastric Lymphoma, Non-Hodgkin Lymphoma, Follicular Lymphoma, and Bone Marrow Aspiration. Dr. Kumar is currently accepting new patients.

Jeffrey Silberberg is a Hematologist and an Oncologist practicing medicine in Freehold Township, New Jersey. Dr. Silberberg is rated as an Advanced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Angiosarcoma, Paget Disease of the Breast, Breast Cancer, Pleuropulmonary Blastoma, and Bone Marrow Aspiration. Dr. Silberberg is board certified in American Board Of Internal Medicine. Dr. Silberberg is currently accepting new patients.

Israel Grossman is an Oncologist practicing medicine in Livingston, New Jersey. Dr. Grossman is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 54 other conditions, according to our data. His clinical expertise encompasses Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), Plasmacytoma, Hodgkin Lymphoma, Marginal Zone Lymphoma (MZL), and Bone Marrow Aspiration. Dr. Grossman is currently accepting new patients.

Sari Jacoby is a Hematologist and an Oncologist practicing medicine in Newark, New Jersey. Dr. Jacoby is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), Hodgkin Lymphoma, Relapsed Refractory Multiple Myeloma (RRMM), and Bone Marrow Aspiration. Dr. Jacoby is currently accepting new patients.

Burton Appel is a Pediatric Hematologist Oncology provider practicing medicine in Hackensack, New Jersey. Dr. Appel is rated as an Advanced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), Acute Lymphoblastic Leukemia (ALL), Hodgkin Lymphoma, Leukemia, and Bone Marrow Aspiration. Dr. Appel is board certified in American Board Of Pediatrics and American Board Of Pediatrics.

Michele Donato is an Oncologist and a Hematologist practicing medicine in Hackensack, New Jersey. Dr. Donato is rated as an Advanced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). She is also highly rated in 37 other conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Graft Versus Host Disease (GvHD), Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Colonoscopy. Dr. Donato is board certified in American Board Of Internal Medicine.

Tatyana Feldman is an Oncologist and a Hematologist practicing medicine in Hackensack, New Jersey. Dr. Feldman is rated as an Advanced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). She is also highly rated in 38 other conditions, according to our data. Her clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Mantle Cell Lymphoma (MCL), Bone Marrow Aspiration, and Lymphadenectomy. Dr. Feldman is board certified in American Board Of Internal Medicine and Hematology.

Munir Ghesani is a Radiologist practicing medicine in Princeton, New Jersey. Dr. Ghesani is rated as an Advanced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Smoldering Multiple Myeloma, ALK-Positive Non-Small Cell Lung Cancer, Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), Classical Hodgkin Lymphoma, and Liver Embolization.

Triple board-certified in internal medicine, hematology and medical oncology, Dr. Mohamad Cherry is medical director of Hematology at Atlantic Health System. He joins Atlantic Hematology Oncology from the University of Oklahoma Health Sciences Center's Stephenson Cancer Center, bringing years of clinical knowledge and expertise.With specialty training from some of the nation's most skilled clinicians, Dr. Cherry attained some of his clinical training at the leukemia department at MD Anderson and his fellowship in hematology/oncology from the University of Oklahoma Health Sciences Center's Stephenson Cancer Center. He performed two residencies - an internal medicine residency at Staten Island University Hospital and a laboratory medicine residency at the American University of Beirut Medical Center in Lebanon. Previously, Dr. Cherry attained his medical degree at Lebanese University and performed his internship at Sacre Coeur Hospital-Lebanese University. He also earned a master of science degree in clinical and translational research from University of Oklahoma College of Public Health.Dr. Cherry remains on staff as clinical associate professor of hematology/oncology at University of Oklahoma Health Sciences Center's Stephenson Cancer Center. He is also the director of its hematology/oncology fellowship program and co-chairs the Academy of Teaching Scholars Faculty Development, Education and Mentoring Committee. Other administrative roles include co-chair of the leukemia working group at the Sarah Cannon Research Institute Blood Cancer Consortium.As a principal investigator of multiple clinical trials, Dr. Cherry has performed groundbreaking research in niche areas that include epigenetics and development of new therapeutics in relapsed and refractory blood cancers. He has developed teaching materials and book chapters, and has lectured both nationally and internationally.Dr. Cherry continues to serves as a mentor and an advisor to fellows, residents and medical students. He contributes to continuing education, public health, and professional development, and has won awards and funding for both his research and his clinical pursuits. Dr. Cherry is rated as an Experienced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 44 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Non-Hodgkin Lymphoma, Acute Myeloblastic Leukemia without Maturation, Midline Lethal Granuloma, and Bone Marrow Aspiration. Dr. Cherry is board certified in American Board Of Internal Medicine. Dr. Cherry is currently accepting new patients.

Dr. Charles Farber is a board-certified, fellowship-trained oncologist at Atlantic Hematology Oncology located at Morristown Medical Center’s Carol G. Simon Cancer Center. He maintains a broad-based practice, yet focuses on benign and malignant hematology. Dr. Farber also serves as medical director of Oncology Research Network Development for Atlantic Health System. In this role, he works with the system’s Breakthrough Oncology Accelerator partners, Translational Genomics Research Institute (TGen) and OriginCV, to expand cancer research at Morristown Medical Center and throughout Atlantic Health System. This partnership ensures that patients have access to the newest and most exciting drugs and technologies through clinical trials. In addition to receiving multiple Patient’s Choice Awards, Dr. Farber has been recognized as a Top Doctor in the New York Metro Area, and listed in Inside Jersey magazine’s Top Doctors, and Consumers Research Council’s Guide to America’s Top Oncologists. He is regarded by colleagues and patients as a knowledgeable, compassionate and devoted physician and has been providing expert care to the Morristown community for more than 20 years. Dr. Farber attended New York University School of Medicine for his medical degree and performed his residency and fellowship at Weill Cornell Medical Center. He also earned a master’s degree and PhD from New York University’s Graduate School of Arts and Sciences. Dr. Farber chairs Morristown Medical Center’s cancer subcommittee for adolescents and young adults and serves as secretary and treasurer of the Oncology Society of New Jersey. He was former chief of the division of Hematology/Oncology at Morristown Medical Center from 2007 to 2011. Dr. Farber serves as a clinical assistant professor at Rutgers and at the Cancer Institute of New Jersey. His research has been published in the Journal of the American Nutraceutical Association, the New England Journal of Medicine and the National Cancer Institute’s Clinical Trial Directory. Dr. Farber is rated as an Experienced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Non-Hodgkin Lymphoma, Follicular Lymphoma, and Bone Marrow Aspiration. Dr. Farber is board certified in American Board Of Internal Medicine. Dr. Farber is currently accepting new patients.

Beaula Koduri is a Hematologist and an Internal Medicine provider practicing medicine in Edison, New Jersey. Dr. Koduri is rated as an Experienced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Anemia, Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, and Dehydration. Dr. Koduri is board certified in American Board Of Internal Medicine. Dr. Koduri is currently accepting new patients.

With his many speaking engagements and commitment to education, Dr. Neil Morganstein has a reputation as a leader in the treatment of hematological and oncological issues. He is a national speaker in the area of multiple myeloma, as well as co-chair of a video conference on the management of patients with multiple myeloma. He has a special interest in lung cancer and multiple myeloma, and has published and presented several peer-reviewed articles, posters and abstracts at regional and national oncology meetings. These have focused on multiple myeloma, lymphoma, prostate cancer, gastric cancer, and hematological complications during pregnancy.As an involved and committed oncologist at Overlook Medical Center’s Carol G. Simon Cancer Center, Dr. Morganstein gives several lectures a year educating medical students. He teaches the hematology board review course for the American College of Physicians, as well as the hematology and oncology course for residents at Rutgers University. In addition, he thoroughly enjoys working with medical students in the hospital.Dr. Morganstein completed his hematology and oncology fellowship at Robert Wood Johnson University Hospital of New Brunswick, New Jersey, where he also finished his residency training, while serving as chief resident. He is board-certified in medical oncology, hematology and internal medicine and maintains membership in many distinguished organizations, including the American Society of Clinical Oncologists and the American Society of Hematologists. Dr. Morganstein is rated as an Experienced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, Classical Hodgkin Lymphoma, Hodgkin Lymphoma, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Bone Marrow Aspiration. Dr. Morganstein is board certified in American Board Of Internal Medicine. Dr. Morganstein is currently accepting new patients.

James R. Wong, MD, is a radiation oncologist and founder and medical director of the Leonard B. Kahn Head and Neck Cancer Institute at Morristown Medical Center. He specializes in treating head and neck cancers, nasopharyngeal cancer, breast cancer, gastrointestinal cancer, brain tumors and prostate cancer. In 1997, Dr. Wong was named chair of Radiation Oncology at Morristown Medical Center where he presided over the reorganization and development of the new Department of Radiation Oncology. A year later, he was appointed associate clinical professor of radiation oncology at Columbia University, College of Physicians and Surgeons. In 2004, he was appointed by New Jersey Governor Jim McGreevey to the task force on the Prevention, Detection and Treatment of Cancer.Recently, Dr. Wong has developed an interest in incorporating Integrative Medicine and complementary supportive care in the treatment and recovery plans for his patients. Dr. Wong has launched “Integrate to Wellness,” a ten-week program using therapies such as acupuncture and stress management. Before arriving at Atlantic Health System, Dr. Wong served as assistant professor of radiology at the New York Hospital, Cornell University Medical College. He was also the director of radiation oncology fellows and the director of radiation oncology research at the New York Hospital/Cornell Medical Center. At the Stich Radiation Center of New York Hospital, he was in charge of radiation therapy for brain tumors and stereotactic radiosurgery.Graduating summa cum laude from Harvard College, Dr. Wong received his medical degree from Harvard Medical School where he became one of the few honor graduates of his year. He practiced internal medicine at the New England Deaconess Hospital, Harvard Medical School, and continued on for four more years of specialty training in radiation oncology at the Harvard Joint Center for Radiation Therapy. During his 15 years at Harvard, he published many articles in leading scientific journals, including Proceedings of the National Academy of Science, Cell, Journal of Biochemistry, and Cancer Research.Dr. Wong has been selected as one of the “Top Prostate Cancer Specialists” in the United States and is considered a pioneer of image-guided radiation therapy. He was elected by his peers for inclusion in “Best Doctors in America®” for five consecutive years. He is affiliated with Atlantic Medical Group, and is a participating provider of Atlantic Accountable Care Organization. Dr. Wong is rated as an Experienced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Adenoid Cystic Carcinoma, Laryngeal Cancer, Thymic Epithelial Tumor, and Familial Prostate Cancer. Dr. Wong is board certified in American Board Of Radiology. Dr. Wong is currently accepting new patients.

Jason Levitz is a Hematologist and an Oncologist practicing medicine in Denville, New Jersey. Dr. Levitz is rated as an Experienced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Polycythemia Vera, Colorectal Cancer, Familial Colorectal Cancer, Paget Disease of the Breast, and Bone Marrow Aspiration. Dr. Levitz is board certified in American Board Of Internal Medicine. Dr. Levitz is currently accepting new patients.

Rama Sudhindra is a Hematologist practicing medicine in Camden, New Jersey. He has been practicing medicine for over 56 years. Dr. Sudhindra is rated as an Advanced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), Hodgkin Lymphoma, Breast Cancer, and Paget Disease of the Breast. Dr. Sudhindra is board certified in American Board Of Internal Medicine,Medical Oncology , 1979 and American Board Of Internal Medicine,Internal Medicine , 1975.

Roger Strair is a Hematologist Oncology provider practicing medicine in Voorhees, New Jersey. He has been practicing medicine for over 45 years. Dr. Strair is rated as an Advanced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 37 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Multiple Myeloma, Chronic B-Cell Leukemia (CBCL), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Strair is board certified in American Board Of Internal Medicine,Medical Oncology , 1987, American Board Of Internal Medicine,Hematology , 1986, and American Board Of Internal Medicine,Internal Medicine , 1984.

Tulin Budak is an Oncologist practicing medicine in Camden, New Jersey. She has been practicing medicine for over 39 years. Dr. Budak is rated as an Advanced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). She is also highly rated in 31 other conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Chronic Lymphocytic Leukemia (CLL), Deep Vein Thrombosis, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Budak is board certified in American Board Of Internal Medicine,Hematology , 2012, American Board Of Internal Medicine,Medical Oncology , 2012, and American Board Of Internal Medicine,Internal Medicine , 2012.

Bruno Fang is a Hematologist Oncology provider practicing medicine in East Brunswick, New Jersey. Dr. Fang is rated as an Experienced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Hodgkin Lymphoma, Pleuropulmonary Blastoma, and Familial Colorectal Cancer. Dr. Fang is board certified in American Board Of Internal Medicine and Internal Medicine.